title: Porous scaffolds support extrahepatic human islet transplantation, engraftment, and function in mice.
abstract: Islet transplantation as a therapy or cure for type 1 diabetes has significant promise but has been limited by islet mass requirements and long-term graft failure. The intrahepatic and intravascular site may be responsible for significant loss of transplanted islets. Nonencapsulating biomaterial scaffolds provide a strategy for architecturally defining and modulating extrahepatic sites beyond the endogenous milieu to enhance islet survival and function. We utilized scaffolds to transplant human islets into the intraperitoneal fat of immunodeficient mice. A smaller human islet mass than previously reported reversed murine diabetes and restored glycemic control at human blood glucose levels. Graft function was highly dependent on the islet number transplanted and directly correlated to islet viability, as determined by the ATP-to-DNA ratio. Islets engrafted and revascularized in host tissue, and glucose tolerance testing indicated performance equivalent to healthy mice. Addition of extracellular matrix, specifically collagen IV, to scaffold surfaces improved graft function compared to serum-supplemented media. Porous scaffolds can facilitate efficient human islet transplantation and provide a platform for modulating the islet microenvironment, in ways not possible with current clinical strategies, to enhance islet engraftment and function.
authors.affiliation: Institute of Bionanotechnology in Medicine (IBNAM), Northwestern University, Chicago, IL, USA.
authors.forename: Romie F
authors.initials: RF
authors.lastname: Gibly
authors.forename: Xiaomin
authors.initials: X
authors.lastname: Zhang
authors.forename: William L
authors.initials: WL
authors.lastname: Lowe
authors.forename: Lonnie D
authors.initials: LD
authors.lastname: Shea
mesh_terms: D000273:Adipose Tissue / Q000473:pathology; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D024141:Collagen Type IV / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000401:mortality / Q000628:therapy*; D005109:Extracellular Matrix / Q000378:metabolism; D006085:Graft Survival; D006801:Humans; D007263:Infusions, Parenteral; D016381:Islets of Langerhans Transplantation; D053208:Kaplan-Meier Estimate; D008297:Male; D051379:Mice; D016688:Mice, Inbred NOD; D008863:Microspheres; D011098:Polyglactin 910 / Q000737:chemistry; D016062:Porosity; D054457:Tissue Scaffolds
chemical_list: D001786:Blood Glucose; D024141:Collagen Type IV; D011098:Polyglactin 910